Related references
Note: Only part of the references are listed.Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9-tetrahydrocannabinol: a pilot study
Erica N. Peters et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants
Erica N. Peters et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2022)
Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue
Robert B. Child et al.
NUTRIENTS (2022)
Use and Perceptions of Cannabidiol Products in Canada and in the United States
Samantha Goodman et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Sex differences in the acute effects of oral and vaporized cannabis among healthy adults
Dennis J. Sholler et al.
ADDICTION BIOLOGY (2021)
Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol
Jessica L. Beers et al.
DRUG METABOLISM AND DISPOSITION (2021)
The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives
Yue Zu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults
Justin Matheson et al.
PSYCHOPHARMACOLOGY (2020)
Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users
Tory R. Spindle et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
A systematic review of cannabidiol dosing in clinical populations
S. A. Millar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
Katharina Knaub et al.
MOLECULES (2019)
Drug-induced liver injury
Raul J. Andrade et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Human Pharmacokinetic Parameters of Orally Administered Δ9-Tetrahydrocannabinol Capsules Are Altered by Fed Versus Fasted Conditions and Sex Differences
Stephanie Lunn et al.
CANNABIS AND CANNABINOID RESEARCH (2019)
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Delta(9)-Tetrahydrocannabinol
Douglas L. Boggs et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Ziva D. Cooper et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI
Rosa Chan et al.
TOXICOLOGICAL SCIENCES (2018)
Mechanisms of canalicular transporter endocytosis in the cholestatic rat liver
Gisel S. Miszczuk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine
Jelena Klawitter et al.
THERAPEUTIC DRUG MONITORING (2017)
Drug dosing in obese adults
Michael Barras et al.
AUSTRALIAN PRESCRIBER (2017)
Sex Differences in the Pharmacokinetics of Antidepressants: Influence of Female Sex Hormones and Oral Contraceptives
Valerie A. Damoiseaux et al.
CLINICAL PHARMACOKINETICS (2014)
Understanding the Transport Properties of Metabolites: Case Studies and Considerations for Drug Development
Maciej J. Zamek-Gliszczynski et al.
DRUG METABOLISM AND DISPOSITION (2014)
Sex Differences in Drug Disposition
Offie P. Soldin et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
Rongrong Jiang et al.
LIFE SCIENCES (2011)
Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
Anna Mazur et al.
DRUG METABOLISM AND DISPOSITION (2009)
Gender and interindividual variability in pharmacokinetics
Jean-Marie Nicolas et al.
DRUG METABOLISM REVIEWS (2009)
Sex Differences in the Pharmacokinetics and Pharmacodynamics of Antidepressants: An Updated Review
Kristin L. Bigos et al.
GENDER MEDICINE (2009)
Sex-specific differences in CYP450 isoforms in humans
Marissa J. Scandlyn et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Δ9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract
T Nadulski et al.
THERAPEUTIC DRUG MONITORING (2005)